NEK3

NEK3 (NIMA-related kinase 3) is a serine/threonine kinase within the NEK family that functions primarily in cytoplasmic signaling rather than canonical cell-cycle regulation, distinguishing it from several other NEK isoforms that are closely linked to mitotic control^[1]. NEK3 regulates cellular architecture through pathways controlling cytoskeletal organization, focal adhesion dynamics, and cell motility, thereby connecting extracellular signals to structural remodeling processes^[1][2]. Mechanistically, NEK3 participates in prolactin receptor signaling through interactions involving VAV2, paxillin (PXN), and RAC1 activation, promoting cytoskeletal reorganization and migratory responses^[1]. In breast cancer models, depletion of NEK3 reduces prolactin-induced RAC1 activation, cell migration, invasion, and paxillin phosphorylation, supporting a functional role in tumor cell motility and invasive behavior^[1]. Further mechanistic studies identified Thr165 as a regulatory phosphorylation site within NEK3, with ERK1/2-dependent phosphorylation modulating focal adhesion remodeling and actin cytoskeleton organization required for efficient breast cancer cell migration^[2]. Compared with related NEK family members that primarily regulate centrosome function, mitosis, or ciliary biology, NEK3 is notable for its association with prolactin-responsive signaling and cytoskeletal regulation in both cancer and neuronal contexts^[1][3]. In addition, NEK3 has been reported to influence neuronal morphogenesis, polarity, and microtubule acetylation, expanding its relevance beyond oncology to studies of cellular organization and signaling networks^[3]. Although NEK family kinases are considered potential therapeutic targets, selective NEK3-directed pharmacological tools remain limited, making genetic perturbation and phosphorylation-site analysis important experimental approaches for mechanistic research^[1].